X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (261) 261
Publication (62) 62
Patent (5) 5
Dissertation (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (177) 177
female (163) 163
adult (107) 107
index medicus (96) 96
uterine cervical neoplasms - virology (87) 87
cervical cancer (86) 86
cancer (71) 71
adolescent (67) 67
papillomavirus infections - virology (66) 66
human papillomavirus (63) 63
risk factors (63) 63
oncology (61) 61
women (61) 61
papillomaviridae - genetics (60) 60
papillomavirus infections (57) 57
cervical intraepithelial neoplasia - virology (56) 56
papillomaviridae - isolation & purification (52) 52
middle aged (48) 48
papillomavirus infections - prevention & control (45) 45
infection (43) 43
cervical intraepithelial neoplasia (42) 42
vaccines (41) 41
young adult (41) 41
article (37) 37
papillomavirus infections - epidemiology (37) 37
uterine cervical neoplasms - prevention & control (36) 36
young-women (36) 36
uterine cervical neoplasms - epidemiology (34) 34
polymerase chain reaction (33) 33
prevention (33) 33
intraepithelial neoplasia (32) 32
public, environmental & occupational health (32) 32
risk (32) 32
uterine cervical neoplasms - pathology (31) 31
infectious diseases (30) 30
research (30) 30
papillomaviridae - classification (29) 29
lesions (28) 28
papillomavirus infections - complications (28) 28
uterine cervical neoplasms - diagnosis (28) 28
cervical intraepithelial neoplasia - pathology (27) 27
cervical intraepithelial neoplasia - epidemiology (26) 26
cervical-cancer (26) 26
genotype (26) 26
undetermined significance (26) 26
dna, viral - analysis (25) 25
double-blind method (25) 25
hpv (25) 25
prevalence (25) 25
randomized-trial (25) 25
vaccination (25) 25
viruses (25) 25
colposcopy (24) 24
female genital diseases and pregnancy complications (24) 24
follow-up studies (24) 24
health aspects (24) 24
microbiology (24) 24
vaginal smears (24) 24
atypical squamous-cells (23) 23
diagnosis (23) 23
united-states (23) 23
cervical intraepithelial neoplasia - diagnosis (22) 22
epidemiology (22) 22
immunology (22) 22
infections (22) 22
aged (21) 21
papillomaviruses (21) 21
virus diseases (21) 21
immunization (20) 20
papillomaviridae - immunology (20) 20
papillomavirus infections - diagnosis (20) 20
papillomavirus infections - pathology (20) 20
papillomavirus vaccines - administration & dosage (20) 20
virology (20) 20
analysis (19) 19
dna (19) 19
particle vaccine (19) 19
abridged index medicus (18) 18
cervical intraepithelial neoplasia - prevention & control (18) 18
dna, viral - genetics (18) 18
management (18) 18
obstetrics & gynecology (18) 18
papillomavirus vaccines (18) 18
neoplasia (17) 17
base sequence (16) 16
human papillomavirus 16 - immunology (16) 16
womens health (16) 16
cervix uteri - virology (15) 15
human papillomavirus 16 - genetics (15) 15
human papillomavirus 18 - immunology (15) 15
medical screening (15) 15
new mexico - epidemiology (15) 15
papillomavirus vaccines - immunology (15) 15
case-control studies (14) 14
early detection of cancer (14) 14
papillomavirus vaccines - therapeutic use (14) 14
age factors (13) 13
cytology interpretations (13) 13
follow-up (13) 13
incidence (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 20 - 21
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S1473-3099(16)30540-0 Byline: Cosette M Wheeler (a), Frank Struyf (b)... 
Infectious Disease | Humans | Papillomavirus Infections | Papillomavirus Vaccines | Studies | Clinical trials | Human papillomavirus | Vaccines | Pharmaceutical industry
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 12/2014, Volume 180, Issue 11, p. 1066
  We examined the concurrence of multiple human papillomavirus (HPV) infections in 47,617 women who underwent cervical screening in New Mexico between December... 
Human papillomavirus | Immunization | Immunology | Cellular biology | Womens health | Genetic testing | Medical screening
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2007, Volume 195, Issue 11, pp. 1582 - 1589
Journal Article
Ca : a Cancer Journal for Clinicians, ISSN 0007-9235, 05/2018, Volume 68, Issue 3, p. 199
Timely follow-up for positive cancer screening results remains suboptimal,and the evidence base to inform decisions on optimizing the timeliness of... 
Systematic review | Medical screening | Cervix | Cancer
Journal Article
PLoS Pathogens, ISSN 1553-7366, 06/2015, Volume 11, Issue 6
  Cervical cancer is a multi-stage disease caused by human papillomaviruses (HPV) infection of cervical epithelial cells, but the mechanisms regulating disease... 
Human papillomavirus | Insulin-like growth factors | Rodents | Cervical cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 10/2017, Volume 9, Issue 10, pp. 1327 - 1330
The hypothesis is discussed that prostate cancer marker lncRNAPCA3 was introduced into the human genome by an oncogenic virus, and that viral infection-related... 
RNA viruses | Androgens | Etiology | Genomes | Ribonucleic acid--RNA | Prostate | Prostate cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9574, pp. 1693 - 1702
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 10, pp. 1154 - 1168
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1928 - 1943
Journal Article